Axxess Pharma Inc Announces Expansion of TapouT Product Line Into Latin America With Affiliate Office in Mexico City
November 26 2013 - 8:00AM
Marketwired
Axxess Pharma Inc Announces Expansion of TapouT Product Line Into
Latin America With Affiliate Office in Mexico City
Brazil and Mexico Expected to Be Large Growth Markets for TapouT
Product Line and Cancer Drugs
TORONTO, ON--(Marketwired - Nov 26, 2013) - Axxess Pharma Inc.
(PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional
supplements company is pleased to announce, it will establish
a Latin American division headquartered in Mexico City, Mexico to
handle the Sales & Marketing efforts for the region. Latin
America is widely known for their strong interest in the UFC and
the TapouT product line. Axxess Pharma anticipates strong revenue
within region.
Daniel Bagi, M.D. President of Axxess stated, "The tremendous
popularity of the UFC and TapouT in Latin America, especially in
Brazil and Mexico necessitates our presence on the ground to manage
both our TapouT and pharmaceutical lines. We have already begun the
process of establishing Axxess Pharma as a corporate entity in
Mexico, and expect to begin operations in the New Year, with sales
in the region beginning shortly after." Dr. Bagi, M.D. further
stated, "Latin America as a region has a population of over 500
million and is one of the fastest growing markets in the world.
With the popularity and growth of the UFC and the TapouT brand, we
felt the timing was right for this expansion. We are also very
close to submitting pharmaceutical cancer drug dossiers for
approval in Mexico. In August of 2013, our Company acquired the
Mexican and Latin American rights to the cancer drugs from a
leading Canadian manufacturer."
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its
wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc.,
headquartered in Toronto. Axxess is a specialty Health Care
Products Company dedicated to improving health and quality of life
by offering select medicines, nutritional supplements and over the
counter remedies all across the Americas. Axxess's goal is to bring
additional products to the market and provide new, innovative
options for better health spanning areas such as high cholesterol,
blood pressure, acute pain, - to optimal health management through
improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or
contact Investor Relations at (973) 351-3868.
Safe Harbor Statement
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor
(973) 351-3868 STEPHTAYL9@AOL.COM www.TheStockAlerts.com
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Oct 2024 to Nov 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Nov 2023 to Nov 2024